Security Reports > Exelixis

Exelixis
Data Breaches, Cyber Attacks and Security Report

https://exelixis.com  ᛫  Biotech & Pharmaceuticals
Last updated August 15, 2020

Exelixis Security Rating

${grade.letter}
${cstarScore}
/ 950

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Exelixis is implementing good security practices.

Company Information

Company:
${companyName}
Valuation:
${marketCap}
Employees:
${employees}
Location:
${country}
CEO:
${ceo}

About Exelixis

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.


Data Breaches and Security News


Security Report for Exelixis

Want a security rating for your organization?

This report shows a preliminary security rating for Exelixis. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.

Get a deeper scan

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Exelixis's security performance with other companies